Brasil Pharma Upsizes Debenture

Oct 23, 2013

Brasil Pharma has priced a BRL288m ($132m) domestic bond sale, according to regulatory documents, upsizing from a BRL250m...

To continue reading please take a free trial, subscribe or login below.

Already have an account?


Subscribe now for unlimited access to all current and archive news, data and market analysis. 


Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

Upcoming Events


Where will capital markets be busiest in 2017?